marijuana stocks news

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medbox, Inc. Stockholders

NEW YORK–(BUSINESS WIRE)–

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Medbox, Inc. (“Medbox” or the “Company”) (MDBX) concerning its disclosure of misleading financial statements.

In October 2014, the Company appointed a special board committee which would investigate a federal grand jury subpoena served upon the Company’s accountants, in addition to certain alleged wrongdoing raised by a former employee of the Company. Medbox has since received subpoenas from the federal grand jury and the Securities and Exchange Commission. Upon its investigation, on December 30, 2014, Medbox announced that its financial statements for the year ended December 31, 2013, the third and fourth quarters of 2013, and the first three quarters of 2014 will have to be amended and restated. As part of the Company’s internal investigation it will also review its financial statements for 2012 and the first two quarters of 2013.

If you are a Medbox stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email atbwalker@kmllp.com, or telephone at (212) 699-1145, Melissa Fortunato, Esq. by email atmfortunato@kmllp.com, or telephone at (212) 699-1141, or toll free at (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you.

Kirby McInerney LLP is a New York-based law firm concentrating in securities, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.

Contact:
Kirby McInerney LLP
J. Brandon Walker, Esq., 212-699-1145
bwalker@kmllp.com
or
Melissa Fortunato, Esq., 212-699-1141
mfortunato@kmllp.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PLPL To Produce Non-Psychoactive Cannabis Product

Plandai Biotechnology Collaboration Offers Opportunity to Produce a Non-Psychoactive Cannabis Product for…

 InMed Pharmaceuticals Inc. (IMLFF) and Almac Group Developing Improved Cannabinoid Production Methods

InMed and Almac Group Developing Improved Cannabinoid Production Methods    InMed Pharmaceuticals…

$DIDG Reports Unaudited Revenues And Expenses For FY 2014

The Digital Development Group (DIDG) Reports Unaudited Revenues And Expenses For FY…

MariMed, Inc (MRMD) Opens its First Medical Cannabis Dispensary in Maryland

MariMed Opens its First Medical Cannabis Dispensary in Maryland, Will Host a…